447 related articles for article (PubMed ID: 35096486)
41. Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics.
Patwardhan KA; RaviPrakash H; Nikolaou N; Gonzalez-García I; Salazar JD; Metcalfe P; Reischl J
Front Immunol; 2024; 15():1383644. PubMed ID: 38915397
[TBL] [Abstract][Full Text] [Related]
42. CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.
Lin Q; Wu HJ; Song QS; Tang YK
Front Oncol; 2022; 12():937277. PubMed ID: 36267975
[TBL] [Abstract][Full Text] [Related]
43. Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer.
Cong M; Yao H; Liu H; Huang L; Shi G
Medicine (Baltimore); 2020 May; 99(18):e20074. PubMed ID: 32358390
[TBL] [Abstract][Full Text] [Related]
44. CT-based radiomics signature to predict CD8+ tumor infiltrating lymphocytes in non-small-cell lung cancer.
Chen Y; Xu T; Jiang C; You S; Cheng Z; Gong J
Acta Radiol; 2023 Apr; 64(4):1390-1399. PubMed ID: 36120843
[TBL] [Abstract][Full Text] [Related]
45. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
46. A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Yolchuyeva S; Giacomazzi E; Tonneau M; Ebrahimpour L; Lamaze FC; Orain M; Coulombe F; Malo J; Belkaid W; Routy B; Joubert P; Manem VSK
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568646
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.
Li Y; Wang P; Xu J; Shi X; Yin T; Teng F
Oncoimmunology; 2024; 13(1):2312628. PubMed ID: 38343749
[TBL] [Abstract][Full Text] [Related]
48. Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients.
Caii W; Wu X; Guo K; Chen Y; Shi Y; Chen J
Cancer Immunol Immunother; 2024 Jun; 73(8):153. PubMed ID: 38833187
[TBL] [Abstract][Full Text] [Related]
49. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
[TBL] [Abstract][Full Text] [Related]
50.
Polverari G; Ceci F; Bertaglia V; Reale ML; Rampado O; Gallio E; Passera R; Liberini V; Scapoli P; Arena V; Racca M; Veltri A; Novello S; Deandreis D
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380754
[TBL] [Abstract][Full Text] [Related]
51. Feature selection methodology for longitudinal cone-beam CT radiomics.
van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
[TBL] [Abstract][Full Text] [Related]
52. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
53. Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study.
Sun J; Li F; Yang J; Lin C; Zhou X; Liu N; Zhang B; Song G; Wang W; Huang C; Song Z; Shi L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7341-7353. PubMed ID: 36928998
[TBL] [Abstract][Full Text] [Related]
54. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
55. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
Tang X; Huang H; Du P; Wang L; Yin H; Xu X
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
[TBL] [Abstract][Full Text] [Related]
56. Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer.
Shao H; Zhu J; Shi L; Yao J; Wang Y; Ma C; Swierniak A; Ni B
J Thorac Dis; 2024 May; 16(5):3213-3227. PubMed ID: 38883654
[TBL] [Abstract][Full Text] [Related]
57. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy.
Chen X; Tong X; Qiu Q; Sun F; Yin Y; Gong G; Xing L; Sun X
Acad Radiol; 2022 Feb; 29 Suppl 2():S53-S61. PubMed ID: 33308945
[TBL] [Abstract][Full Text] [Related]
58. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
59. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
60. Importance of CT image normalization in radiomics analysis: prediction of 3-year recurrence-free survival in non-small cell lung cancer.
Park D; Oh D; Lee M; Lee SY; Shin KM; Jun JS; Hwang D
Eur Radiol; 2022 Dec; 32(12):8716-8725. PubMed ID: 35639142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
